LHRH-Conjugated Drugs as Targeted Therapeutic Agents for the Specific Targeting and Localized Treatment of Triple Negative Breast Cancer

Bulk chemotherapy and drug release strategies for cancer treatment have been associated with lack of specificity and high drug concentrations that often result in toxic side effects. This work presents the results of an experimental study of cancer drugs (prodigiosin or paclitaxel) conjugated to Lut...

Descripción completa

Detalles Bibliográficos
Autores principales: Obayemi, J. D., Salifu, A. A., Eluu, S. C., Uzonwanne, V. O., Jusu, S. M., Nwazojie, C. C., Onyekanne, C. E., Ojelabi, O., Payne, L., Moore, C. M., King, J. A., Soboyejo, W. O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7237454/
https://www.ncbi.nlm.nih.gov/pubmed/32427904
http://dx.doi.org/10.1038/s41598-020-64979-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7237454/
https://www.ncbi.nlm.nih.gov/pubmed/32427904
http://dx.doi.org/10.1038/s41598-020-64979-1

Ejemplares similares